Related Experiment Video

Updated: Jun 14, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Castrate-resistant prostate cancer: therapeutic strategies

Andrea L Harzstark1, Eric J Small

  • 1University of California, Urologic Oncology, San Francisco, CA 94143, USA.Andrea.harzstark@ucsf.edu

Expert Opinion on Pharmacotherapy
|March 24, 2010
PubMed
Abstract

Insights

New therapies are emerging for castrate-resistant prostate cancer (CRPC), offering hope where current treatments fall short. This review covers advancements in chemotherapy, immunotherapy, and targeted agents for CRPC.

Area of Science:

  • Oncology
  • Urology
  • Prostate Cancer Research

Background:

  • Castrate-resistant prostate cancer (CRPC) presents significant unmet clinical needs.
  • Current therapeutic options for CRPC are limited in efficacy.

Purpose of the Study:

  • To review recent advancements in therapeutic strategies for CRPC.
  • To provide an overview of novel agents and treatment modalities.

Main Methods:

  • Comprehensive literature review of emerging CRPC therapies.
  • Discussion of new chemotherapies, antiangiogenic agents, immunotherapy, and targeted drugs.

Main Results:

  • Several novel therapeutic approaches are under active investigation for CRPC.
  • Emerging treatments include new chemotherapy regimens, immunotherapy, and targeted agents like endothelin-A receptor antagonists and clusterin inhibitors.

Conclusions:

  • Multiple therapeutic strategies targeting diverse pathways are being developed for CRPC.
  • The landscape of CRPC treatment is evolving with promising new agents.

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Murine Prostate Micro-dissection and Surgical Castration08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...